MAK CAPITAL ONE LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1385702
Institutional-grade research for retail investors
Email me the moment this fund files its next 13F

13F Reported Value

$713.8M

Holdings

17

Latest Filing

2026-06-30

Filing Quarter

Q2 2026

Portfolio Overview

MAK CAPITAL ONE LLC disclosed 17 positions worth $713.8M in its Form 13F-HR for Q2 2026, led by $AGYS (AGILYSYS INC) at 17.5% of the equity portfolio, followed by $GGAL and $ACHC. During the quarter the fund opened 1 new position and exited 6 — including a new stake in $CAI and a full exit from $SKY. The portfolio is most concentrated in Healthcare (43.8% of disclosed assets). All figures are sourced directly from MAK CAPITAL ONE LLC’s Form 13F-HR filing with the SEC under CIK 1385702.

Sector Allocation

HealthcareTechnologyFinancialsIndustrialsConsumer DiscretionaryMaterials

AUM History

Top Equity Holdings by Value

Quarterly Activity — Q2 2026

Click any card to unlock

Top Holdings

AI Quality Scored

Unlock AI quality scores for every holding

32-signal composite ranking on each of MAK CAPITAL ONE LLC's 17 positions.

Showing top 10 of 17 holdings.

Sector Allocation

Healthcare

$312.8M

Technology

$148.3M

Financials

$115.4M

Industrials

$55.7M

Consumer Discretionary

$28.9M

Materials

$21.6M

Energy

$16.2M

Utilities

$14.8M

Full HoldingsMAK CAPITAL ONE LLC (Q2 2026)

All 17 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.

TickerCompanyValue
AGYS$AGYSAGILYSYS INC$124.6M
GGAL$GGALGRUPO FINANCIERO GALICIA SA$74.3M
ACHC$ACHCAcadia Healthcare Company, Inc.$71.8M
QURE$QUREuniQure N.V.$56.7M
SKY$SKYChampion Homes, Inc.$55.7M
AUTL$AUTLAutolus Therapeutics plc$53.8M
CLPT$CLPTClearPoint Neuro, Inc.$42.4M
SUPV$SUPVGrupo Supervielle S.A.$41.1M
CAI$CAICaris Life Sciences, Inc.$34.5M
ANNX$ANNXAnnexon, Inc.$33.5M
LAB$LABSTANDARD BIOTOOLS INC.$23.7M
LODE$LODEComstock Inc.$21.6M
CYRX$CYRXCryoport, Inc.$20.1M
HNST$HNSTHonest Company, Inc.$17.5M
CVE$CVECENOVUS ENERGY INC.$16.2M
PESI$PESIPERMA FIX ENVIRONMENTAL SERVICES INC$14.8M
YTRA$YTRAYatra Online, Inc.$11.5M

New Positions (1)

CAI$CAI Caris Life Sciences, Inc.$34.5M

Exited Positions (6)

SKY$SKYPUT Champion Homes, Inc.
COUR$COUR Coursera, Inc.
UDMY$UDMY Udemy, Inc.
PLX$PLX Protalix BioTherapeutics, Inc.
FVRR$FVRR Fiverr International Ltd.
SGMO$SGMO SANGAMO THERAPEUTICS, INC

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

Available Analysis

13F Pro tracks comprehensive institutional data for MAK CAPITAL ONE LLC including:

Full 13F portfolio with all holdings
Quarter-over-quarter position changes
Accumulation & distribution patterns
Sector allocation breakdown
Historical portfolio evolution
New positions & complete exits
Concentration analysis
Peer comparison with similar funds
AI-powered portfolio insights

Track MAK CAPITAL ONE LLC's Full Portfolio

See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for MAK CAPITAL ONE LLC and 8,700+ other institutional investors.

View Pricing

Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

AI-Powered Hedge Fund Analysis: MAK CAPITAL ONE LLC

13F Pro is an AI hedge fund tracker and stock research platform. For MAK CAPITAL ONE LLC (SEC CIK: 1385702), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in MAK CAPITAL ONE LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.